117 related articles for article (PubMed ID: 6164883)
1. Application of human leucocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma.
Ikić D; Nola P; Maricić Z; Smudj K; Oresić V; Knezević M; Rode B; Jusić D; Soos E
Lancet; 1981 May; 1(8228):1022-4. PubMed ID: 6164883
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte interferon in therapy of patients with urinary bladder papillomatosis, breast cancer, and melanoma.
Maricić Z; Nola P; Ikić D; Smudj K; Oresić V; Knezević M; Rode B; Jusić D; Soos E
J Cancer Res Clin Oncol; 1981; 101(3):317-23. PubMed ID: 6171574
[TBL] [Abstract][Full Text] [Related]
3. Application of human leucocyte interferon in patients with tumours of the head and neck.
Ikić D; Padovan I; Brodarec I; Knezević M; Soos E
Lancet; 1981 May; 1(8228):1025-7. PubMed ID: 6164884
[TBL] [Abstract][Full Text] [Related]
4. Interferon therapy in neoplastic disease. A preliminary report.
Christophersen IS; Jordal R; Osther K; Lindenberg J; Pedersen PH; Berg K
Acta Med Scand; 1978; 204(6):471-6. PubMed ID: 282780
[TBL] [Abstract][Full Text] [Related]
5. Interferons in the treatment of human cancer.
Kirkwood JM; Ernstoff MS
J Clin Oncol; 1984 Apr; 2(4):336-52. PubMed ID: 6323641
[TBL] [Abstract][Full Text] [Related]
6. Evolution and prognosis of bladder papillomatosis managed by endoscopic resection and endovesical BCG therapy : about 24 cases.
Sallami S; Gammoudi A; Cherni R; Chelly I; Horchani A
Tunis Med; 2013 Oct; 91(10):573-6. PubMed ID: 24281996
[TBL] [Abstract][Full Text] [Related]
7. [Reoperation for severe hematuria following chemotherapy for bladder papillomatosis previously treated by surgery and cobalt therapy].
Sauvage R
Acta Urol Belg; 1981 Jan; 49(1):36-43. PubMed ID: 6782845
[No Abstract] [Full Text] [Related]
8. Bladder papilloma: therapeutic and cost effect of outpatient department management.
Klein FA; Whitmore WF
Urology; 1981 Sep; 18(3):247-9. PubMed ID: 6792764
[TBL] [Abstract][Full Text] [Related]
9. Application of human leucocyte interferon in patients with carcinoma of the uterine cervix.
Ikić D; Krusić J; Kirhmajer V; Knezević M; Maricić Z; Rode B; Jusić D; Soos E
Lancet; 1981 May; 1(8228):1027-30. PubMed ID: 6164885
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
11. Treatment of papillomatosis of the urinary bladder with phenol and glycerin.
Vermooten V
Pac Med Surg; 1968; 76(1):40-2. PubMed ID: 5294011
[No Abstract] [Full Text] [Related]
12. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
[TBL] [Abstract][Full Text] [Related]
13. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
Korovin AI; Savvin VT
Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
[TBL] [Abstract][Full Text] [Related]
14. Bladder hyperthermia in the treatment of vesical papillomatosis.
Lunglmayr G; Czech K; Zekert F; Kellner G
Int Urol Nephrol; 1973 Jan; 5(1):75-84. PubMed ID: 4203803
[No Abstract] [Full Text] [Related]
15. [Results of combined surgical and radiological treatment of bladder cancer with particular reference to local tumor recurrence].
Hoffmann L; Günther M; Kittner H; Hudemann B; Ziegler PG
Z Urol Nephrol; 1981 Jun; 74(6):427-35. PubMed ID: 7257633
[TBL] [Abstract][Full Text] [Related]
16. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources.
Sessions RB; Goepfert H; Donovan DT; Dichtel WJ; Gutterman JU
Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):456-61. PubMed ID: 6194728
[TBL] [Abstract][Full Text] [Related]
17. Influence of interferon on C19-steroids in urine of malignant skin melanoma and malignant breast neoplasm patients.
Marković L; Ivanović S; Konstantinović I; Ikić D; Micić J; Stakić B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):416-8. PubMed ID: 6238002
[TBL] [Abstract][Full Text] [Related]
18. [Biological significance of urinary bladder papilloma. (Evaluation of ambulatory treatment of 15-year duration)].
Bohlmann A
Z Urol Nephrol; 1974 Dec; 67(12):885-96. PubMed ID: 4460600
[No Abstract] [Full Text] [Related]
19. Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.
Romics I; Horváth J; Fehér J; Csontai A
Int Urol Nephrol; 1985; 17(4):323-30. PubMed ID: 3835174
[TBL] [Abstract][Full Text] [Related]
20. [Interferon and therapy of oncological diseases].
Andzhaparidze OG; Pille ER
Vopr Virusol; 1989; 34(5):517-23. PubMed ID: 2481902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
